IBS & irritable bowel — all decisions

The Board granted service connection for the cause of death, finding that the Veteran's substance abuse disorder was a means to self-medicate symptoms associated with his service-connected psychiatric disabilities and contributed substantially or materially to his death.

The Board found that the discontinuance of the 100 percent evaluation for gastric carcinoid, status post partial gastrectomy effective June 1, 2023, was proper and denied a rating in excess of 60 percent from June 1, 2023, for gastric carcinoid status post partial gastrectomy residuals.

The Board remands the claim for an initial rating in excess of 30 percent for IBS and GERD with hiatal hernia and Barrett's esophagus to correct a duty to assist error.

The Board remands all service connection claims for further development, specifically to provide the veteran with adequate VA examinations.

The Board granted service connection for prostate cancer residuals and remanded the claims for an acquired psychiatric disability, irritable bowel syndrome (IBS), chronic bronchitis, rhinitis, and sinusitis.

The Board granted service connection for tinnitus and a lumbar spine disability, while denying service connection for bilateral hearing loss, chronic gastritis, gastroesophageal reflux disease, irritable bowel syndrome, and assigning a 20 percent rating for residuals of a neuroendocrine tumor of the stomach.

The Board remands the claims for service connection for gastroesophageal reflux disease, irritable bowel syndrome, right foot plantar fasciitis, and bilateral hand joint pain to correct pre-decisional duty to assist errors.

The Board granted an initial disability rating of 30 percent for the Veteran's service-connected irritable bowel syndrome, resolving all doubt in favor of the Veteran.

The Board granted service connection for pseudofolliculitis and bilateral lower extremity peripheral neuropathy, but denied increased ratings for the Veteran's foot, cervical spine, lumbosacral spine, psychiatric disorder, and other conditions.

The Board denied a disability rating in excess of 70 percent for PTSD, finding that the Veteran's symptoms more closely approximated those associated with a 70 percent rating.

The appeal seeking a compensable rating for irritable bowel syndrome (IBS) was dismissed as the Veteran's December 2024 Notice of Disagreement was not valid due to concurrent election of administrative review options.

The Board granted service connection for tinnitus and denied it for chronic fatigue syndrome (CFS). The remaining claims for various other conditions were remanded for further development.

The Board denied service connection for rhinitis, sinusitis, and irritable bowel syndrome (IBS) as there is no evidence of a current diagnosis or etiology related to the Veteran's service.

The Board denied service connection for PTSD, non-allergic rhinitis, right hip strain, IBS, and tinnitus. The claims for increased ratings were also denied.

The Board denied service connection for dysuria and remanded claims for service connection for GERD, IBS, and a neck disability to correct pre-decisional duty to assist errors.

The Board granted service connection for erectile dysfunction, IBS, a left hip disorder, a left shin splint disorder, a left wrist disorder, and sleep apnea. The claims for service connection for a low back disorder, TBI, left hamstring disorder, migraine headache disorder, right hamstring disorder, right hip disorder, right shin splint disorder, and right wrist disorder were denied.

The Board denied an earlier effective date for the 60 percent rating assigned for the Veteran's service-connected gastrointestinal disability and the award of Dependents' Educational Assistance (DEA) benefits.

The Board denied the Veteran's claims for service connection for low back condition, left leg radiculopathy, right leg radiculopathy, and irritable bowel syndrome (IBS) as there was no evidence to support a causal relationship between these conditions and his active duty service.

The Board denied service connection for a chronic gastrointestinal disability, to include irritable bowel syndrome (IBS), and remanded claims for bilateral plantar fasciitis, temporomandibular joint dysfunction (TMJ), cervical spine, lumbar spine, left knee, and left ankle disabilities.

The Board granted service connection for hypertension, erectile dysfunction, and obstructive sleep apnea but denied service connection for skin condition, bilateral hearing loss, and upper respiratory condition. The effective date for the granted conditions is February 14, 2023.